QSAR analysis of poliovirus inhibition by dual combinations of antivirals

[1]  Eugene N Muratov,et al.  Existing and Developing Approaches for QSAR Analysis of Mixtures , 2012, Molecular informatics.

[2]  J. Leszczynski,et al.  QSAR analysis of nitroaromatics' toxicity in Tetrahymena pyriformis : structural factors and possible modes of action , 2012 .

[3]  A Tropsha,et al.  QSAR analysis of the toxicity of nitroaromatics in Tetrahymena pyriformis: structural factors and possible modes of action , 2011, SAR and QSAR in environmental research.

[4]  Michaela Schmidtke,et al.  QSAR analysis of [(biphenyloxy)propyl]isoxazoles: agents against coxsackievirus B3. , 2011, Future medicinal chemistry.

[5]  Alexander Tropsha,et al.  Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research , 2010, J. Chem. Inf. Model..

[6]  Eugene N Muratov,et al.  Per aspera ad astra: application of Simplex QSAR approach in antiviral research. , 2010, Future medicinal chemistry.

[7]  Alexander Tropsha,et al.  Best Practices for QSAR Model Development, Validation, and Exploitation , 2010, Molecular informatics.

[8]  Alexander Tropsha,et al.  Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. , 2010, Chemical research in toxicology.

[9]  Victor Kuzmin,et al.  Application of Random Forest Approach to QSAR Prediction of Aquatic Toxicity , 2009, J. Chem. Inf. Model..

[10]  Humberto González-Díaz,et al.  Multi-target spectral moment: QSAR for antiviral drugs vs. different viral species. , 2009, Analytica chimica acta.

[11]  Jerzy Leszczynski,et al.  Consensus QSAR Modeling of Phosphor‐Containing Chiral AChE Inhibitors , 2009 .

[12]  E. Muratov,et al.  QSAR Analysis of Antimicrobial Activity of 4‐thiazolidone Derivatives , 2009 .

[13]  Igor V. Tetko,et al.  Inductive Transfer of Knowledge: Application of Multi-Task Learning and Feature Net Approaches to Model Tissue-Air Partition Coefficients , 2009, J. Chem. Inf. Model..

[14]  E. De Clercq,et al.  Selective inhibitors of picornavirus replication , 2008, Medicinal research reviews.

[15]  J. Leszczynski,et al.  The effect of nitroaromatics' composition on their toxicity in vivo: novel, efficient non-additive 1D QSAR analysis. , 2008, Chemosphere.

[16]  Jerzy Leszczynski,et al.  The effects of characteristics of substituents on toxicity of the nitroaromatics: HiT QSAR study , 2008, J. Comput. Aided Mol. Des..

[17]  Victor Kuzmin,et al.  Hierarchical QSAR technology based on the Simplex representation of molecular structure , 2008, J. Comput. Aided Mol. Des..

[18]  G. Lu,et al.  Quantitative structure-activity relationships for joint toxicity of substituted phenols and anilines to Scenedesmus obliquus. , 2008, Journal of environmental sciences.

[19]  Alexander Golbraikh,et al.  Predictive QSAR modeling workflow, model applicability domains, and virtual screening. , 2007, Current pharmaceutical design.

[20]  E. Muratov,et al.  Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication. , 2007, Journal of medicinal chemistry.

[21]  P Wutzler,et al.  Identification of individual structural fragments of N,N'-(bis-5-nitropyrimidyl)dispirotripiperazine derivatives for cytotoxicity and antiherpetic activity allows the prediction of new highly active compounds. , 2007, The Journal of antimicrobial chemotherapy.

[22]  C. Hansch,et al.  Understanding human rhinovirus infections in terms of QSAR. , 2007, Virology.

[23]  Li Zhang,et al.  Computer-based QSARs for predicting mixture toxicity of benzene and its derivatives. , 2007, Chemosphere.

[24]  M. Pallansch,et al.  Vaccine-derived polioviruses and the endgame strategy for global polio eradication. , 2005, Annual review of microbiology.

[25]  Cinzia Conti,et al.  Synthesis and Anti-Rhinovirus Properties of Fluoro-Substituted Flavonoids , 2005, Antiviral chemistry & chemotherapy.

[26]  E. Muratov,et al.  Investigation of anticancer activity of macrocyclic Schiff bases by means of 4D-QSAR based on simplex representation of molecular structure , 2005, SAR and QSAR in environmental research.

[27]  Håvard Jenssen,et al.  Modelling of anti‐HSV activity of lactoferricin analogues using amino acid descriptors , 2005, Journal of peptide science : an official publication of the European Peptide Society.

[28]  D. Matthews,et al.  Conservation of Amino Acids in Human Rhinovirus 3C Protease Correlates with Broad-Spectrum Antiviral Activity of Rupintrivir, a Novel Human Rhinovirus 3C Protease Inhibitor , 2005, Antimicrobial Agents and Chemotherapy.

[29]  T. M. Dmitrieva,et al.  Selective inhibition of the synthesis of single-stranded RNA of encephalomyocarditis virus by 2-(α-hydroxybenzyl)-benzimidazole in cell-free systems , 2005, Archiv für die gesamte Virusforschung.

[30]  Hugo Kubinyi,et al.  Quantitative structure-activity relationships (QSAR) and molecular modelling in cancer research , 2005, Journal of Cancer Research and Clinical Oncology.

[31]  D. Wei,et al.  QSAR-based toxicity classification and prediction for single and mixed aromatic compounds , 2004, SAR and QSAR in environmental research.

[32]  K. Yin,et al.  Development of QSARs for predicting the joint effects between cyanogenic toxicants and aldehydes. , 2003, Chemical research in toxicology.

[33]  S. Katz,et al.  Krugman's Infectious Diseases of Children , 2003 .

[34]  K. Yin,et al.  Quantification of joint effect for hydrogen bond and development of QSARs for predicting mixture toxicity. , 2003, Chemosphere.

[35]  R. Altenburger,et al.  Mixture toxicity and its modeling by quantitative structure‐activity relationships , 2003, Environmental toxicology and chemistry.

[36]  M. Sarvà,et al.  Synthesis of new 3-methylthio-5-aryl-4-isothiazolecarbonitriles with broad antiviral spectrum. , 2002, Antiviral research.

[37]  Andreas Grassauer,et al.  Antiviral Effects of Pyrrolidine Dithiocarbamate on Human Rhinoviruses , 2002, Journal of Virology.

[38]  Bo Liu,et al.  Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics. , 2002, Journal of medicinal chemistry.

[39]  Gehui Wang,et al.  Prediction of mixture toxicity with its total hydrophobicity. , 2002, Chemosphere.

[40]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[41]  Eugene N Muratov,et al.  The analysis of structure-anticancer and antiviral activity relationships for macrocyclic pyridinophanes and their analogues on the basis of 4D QSAR models (simplex representation of molecular structure). , 2002, Acta biochimica Polonica.

[42]  C. Cameron,et al.  RNA virus error catastrophe: Direct molecular test by using ribavirin , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  L. Wang,et al.  Development of quantitative structure activity relationships in toxicity prediction of complex mixtures. , 2001, Acta Pharmacologica Sinica.

[44]  Gareth Thomas,et al.  Medicinal Chemistry: An Introduction , 2000 .

[45]  F. Hayden,et al.  In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses. , 2000, Antiviral research.

[46]  F. Ooms,et al.  Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry. , 2000, Current medicinal chemistry.

[47]  A S Galabov,et al.  In vitro inhibitory effects of dual combinations of picornavirus replication inhibitors. , 1999, Acta virologica.

[48]  M. Cikrt,et al.  QSAR Analysis in Mixture Toxicity Assessment , 1998 .

[49]  H. Kubinyi,et al.  Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices. , 1998, Journal of medicinal chemistry.

[50]  J. Flanegan,et al.  Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C , 1997, Journal of virology.

[51]  Luhua Lai,et al.  A New Atom-Additive Method for Calculating Partition Coefficients , 1997, J. Chem. Inf. Comput. Sci..

[52]  Kimito Funatsu,et al.  GA Strategy for Variable Selection in QSAR Studies: GA-Based PLS Analysis of Calcium Channel Antagonists , 1997, J. Chem. Inf. Comput. Sci..

[53]  L. Vance,et al.  Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses , 1996, Journal of virology.

[54]  Hugo Kubinyi,et al.  Evolutionary variable selection in regression and PLS analyses , 1996 .

[55]  L. Vance,et al.  The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus , 1995, Journal of virology.

[56]  Kenneth J. Ryan,et al.  Reviews and Notes: Infectious Diseases: Sherris Medical Microbiology: An Introduction to Infectious Diseases , 1995, Annals of Internal Medicine.

[57]  Paul Geladi,et al.  Interactive variable selection (IVS) for PLS. Part 1: Theory and algorithms , 1994 .

[58]  S. Wold,et al.  A PLS kernel algorithm for data sets with many variables and fewer objects. Part 1: Theory and algorithm , 1994 .

[59]  J. Mallamo,et al.  Antirhinoviral activity of heterocyclic analogs of Win 54954. , 1992, Journal of medicinal chemistry.

[60]  D. R. Tershak,et al.  Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C , 1989, Journal of virology.

[61]  M A McKinlay,et al.  Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus. , 1989, Journal of medicinal chemistry.

[62]  B. Rosenwirth,et al.  Isolation and characterization of an arildone-resistant poliovirus 2 mutant with an altered capsid protein VP1. , 1988, Antiviral research.

[63]  M. Otto,et al.  Inhibition of poliovirus uncoating by disoxaril (WIN 51711). , 1987, Virology.

[64]  V. A. Ginevskaya,et al.  Effect of N-phenyl-N'-3-hydroxyphenylthiourea (PTU-23) on the protein synthesis in Krebs-II cells infected with encephalomyocarditis virus. , 1983, Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious....

[65]  T. M. Dmitrieva,et al.  Inhibitory effect of N-phenyl-N'-3-hydroxyphenylthiourea (PTU-23) on the reproduction of encephalomyocarditis virus in Krebs-II cells. , 1983, Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious....

[66]  A. Galabov.  Thiourea derivatives as specific inhibitors of picorna viruses. , 1979, Arzneimittel-Forschung.

[67]  K. Lonberg-Holm,et al.  Early alteration of poliovirus in infected cells and its specific inhibition. , 1975, The Journal of general virology.

[68]  W. L. Jolly,et al.  Estimation of atomic charges by an electronegativity equalization procedure calibrated with core binding energies , 1973 .